KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to $1.6 million.

  • Biolife Solutions' Change in Accured Expenses rose 48796.99% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year increase of 6778.85%. This contributed to the annual value of $6.5 million for FY2024, which is 22392.61% up from last year.
  • Per Biolife Solutions' latest filing, its Change in Accured Expenses stood at $1.6 million for Q3 2025, which was up 48796.99% from $864000.0 recorded in Q2 2025.
  • In the past 5 years, Biolife Solutions' Change in Accured Expenses registered a high of $7.1 million during Q4 2024, and its lowest value of -$4.3 million during Q1 2025.
  • In the last 5 years, Biolife Solutions' Change in Accured Expenses had a median value of $266000.0 in 2024 and averaged $237578.9.
  • In the last 5 years, Biolife Solutions' Change in Accured Expenses plummeted by 354615.38% in 2021 and then surged by 86053.64% in 2024.
  • Biolife Solutions' Change in Accured Expenses (Quarter) stood at -$1.4 million in 2021, then surged by 195.52% to $1.3 million in 2022, then skyrocketed by 175.06% to $3.7 million in 2023, then skyrocketed by 91.09% to $7.1 million in 2024, then crashed by 77.84% to $1.6 million in 2025.
  • Its last three reported values are $1.6 million in Q3 2025, $864000.0 for Q2 2025, and -$4.3 million during Q1 2025.